253 related articles for article (PubMed ID: 27842913)
1. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.
Randle RW; Balentine CJ; Leverson GE; Havlena JA; Sippel RS; Schneider DF; Pitt SC
Surgery; 2017 Jan; 161(1):137-146. PubMed ID: 27842913
[TBL] [Abstract][Full Text] [Related]
2. Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.
Pena I; Clayman GL; Grubbs EG; Bergeron JM; Waguespack SG; Cabanillas ME; Dadu R; Hu MI; Fellman BM; Li Y; Gross ND; Lai SY; Sturgis EM; Zafereo ME
Head Neck; 2018 Jan; 40(1):79-85. PubMed ID: 29044788
[TBL] [Abstract][Full Text] [Related]
3. Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment.
Krook KA; Fedewa SA; Chen AY
Laryngoscope; 2015 Apr; 125(4):1021-7. PubMed ID: 25583017
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center.
Raue F; Bruckner T; Frank-Raue K
J Clin Endocrinol Metab; 2019 Oct; 104(10):4264-4272. PubMed ID: 31145454
[TBL] [Abstract][Full Text] [Related]
5. Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years.
James BC; Timsina L; Graham R; Angelos P; Haggstrom DA
Surgery; 2019 Jul; 166(1):41-47. PubMed ID: 30904172
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ
JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144
[TBL] [Abstract][Full Text] [Related]
7. Impact of extensive neck dissection on survival from papillary thyroid cancer.
Kandil E; Friedlander P; Noureldine S; Islam T; Tufano RP
ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):330-5. PubMed ID: 21997375
[TBL] [Abstract][Full Text] [Related]
8. Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma.
Kwon H; Kim WG; Sung TY; Jeon MJ; Song DE; Lee YM; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
J Surg Oncol; 2016 Feb; 113(2):152-8. PubMed ID: 26799259
[TBL] [Abstract][Full Text] [Related]
9. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475
[TBL] [Abstract][Full Text] [Related]
10. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.
Roche AM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic analysis of follicular thyroid carcinoma in a single institute over a 15-year period.
Yu XF; Wang WB; Teng XD; Wang HY; Chen X; Wang HH; Ma ZM; Fahey TJ; Teng LS
Eur J Surg Oncol; 2014 Jul; 40(7):869-74. PubMed ID: 24613740
[TBL] [Abstract][Full Text] [Related]
12. Population-Based Assessment of Complications Following Surgery for Thyroid Cancer.
Papaleontiou M; Hughes DT; Guo C; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2017 Jul; 102(7):2543-2551. PubMed ID: 28460061
[TBL] [Abstract][Full Text] [Related]
13. Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients.
Goffredo P; Cheung K; Roman SA; Sosa JA
Ann Surg Oncol; 2013 Mar; 20(3):767-72. PubMed ID: 23111705
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of medullary thyroid cancer: which guidelines should we follow?
Bowen A; Mani N; Penney S; Loughran S; Yap B
J Laryngol Otol; 2015 May; 129(5):478-83. PubMed ID: 25994382
[TBL] [Abstract][Full Text] [Related]
15. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
[TBL] [Abstract][Full Text] [Related]
16. Association between age and disease specific mortality in medullary thyroid cancer.
Sahli ZT; Canner JK; Zeiger MA; Mathur A
Am J Surg; 2021 Feb; 221(2):478-484. PubMed ID: 33010878
[TBL] [Abstract][Full Text] [Related]
17. Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.
Verburg FA; Mäder U; Luster M; Reiners C
Eur J Endocrinol; 2009 Apr; 160(4):619-24. PubMed ID: 19158232
[TBL] [Abstract][Full Text] [Related]
18. Surgically Treated Pediatric Nonpapillary Thyroid Carcinoma.
Golpanian S; Tashiro J; Sola JE; Allen C; Lew JI; Hogan AR; Neville HL; Perez EA
Eur J Pediatr Surg; 2016 Dec; 26(6):524-532. PubMed ID: 26683804
[No Abstract] [Full Text] [Related]
19. Extent of disease and practice patterns for medullary thyroid cancer.
Kebebew E; Greenspan FS; Clark OH; Woeber KA; Grunwell J
J Am Coll Surg; 2005 Jun; 200(6):890-6. PubMed ID: 15922202
[TBL] [Abstract][Full Text] [Related]
20. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
